Still hope for schistosomiasis vaccine

References

• Chitsulo L, Engels D, Montresor A, Savioli L. The global status of schistosomiasis and its control. Acta Trop 2000;77:41-51; PMID:10996119; http://dx.doi.org/10.1016/S0001-706X(00)00122-4
   PubMed Web of Science ®Google Scholar
• Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet 2006;368:1106-1118; PMID:16997665; http://dx.doi.org/10.1016/S0140-6736(06)69440-3
   PubMed Web of Science ®Google Scholar
• King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn 2008;4:65-79; PMID:18322031; http://dx.doi.org/10.1177/1742395307084407
   PubMedGoogle Scholar
• Terer CC, Bustinduy AL, Magtanong RV, Muhoho N, Mungai PL, Muchiri EM, Kitron U, King CH, Mutuku FM. Evaluation of the health-related quality of life of children in Schistosoma haematobium-endemic communities in Kenya:a cross-sectional study. PLoS Negl Trop Dis 2013;7:e2106; PMID:23505590; http://dx.doi.org/10.1371/journal.pntd.0002106
   PubMedGoogle Scholar
• Wu W, Wang W, Huang YX. New insight into praziquantel against various developmental stages of schistosomes. Parasitol Res 2011;109:1501-1507; PMID:21984370; http://dx.doi.org/10.1007/s00436-011-2670-3
   PubMed Web of Science ®Google Scholar
• Doenhoff MJ, Kusel JR, Coles GC, Cioli D. Resistance of Schistosoma mansoni to praziquantel:is there a problem? Trans R Soc Trop Med Hyg 2002;96:465-469; PMID:12474468; http://dx.doi.org/10.1016/S0035-9203(02)90405-0
   PubMed Web of Science ®Google Scholar
• Hotez PJ, Fenwick A. Schistosomiasis in Africa:an emerging tragedy in our global health decade. PLoS Negl Trop Dis 2009;3:e485; PMID:19787054; http://dx.doi.org/10.1371/journal.pntd.0000485
   PubMed Web of Science ®Google Scholar
• Tendler M, Simpson AJ. The biotechnology-value chain:development of Sm14 as a schistosomiasis vaccine. Acta Trop 2008;108:263-266; PMID:18834847; http://dx.doi.org/10.1016/j.actatropica.2008.09.002
   PubMed Web of Science ®Google Scholar
• WHO. PCT databank 2013 [updated 2013 cited 8 March2013] http://www.who.int/neglected_diseases/preventive_chemotherapy/sch/en/index.html
   Google Scholar
• Bergquist NR, Leonardo LR, Mitchell GF. Vaccine-linked chemotherapy:can schistosomiasis control benefit from an integrated approach? Trends Parasitol 2005;21:112-117; PMID:15734657; http://dx.doi.org/10.1016/j.pt.2005.01.001
   PubMed Web of Science ®Google Scholar
• Bergquist R, Utzinger J, McManus DP. Trick or treat:the role of vaccines in integrated schistosomiasis control. PLoS Negl Trop Dis 2008;2:e244; PMID:18575619; http://dx.doi.org/10.1371/journal.pntd.0000244
   PubMed Web of Science ®Google Scholar
• Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, Cerqueira GC, Mashiyama ST, Al-Lazikani B, Andrade LF, Ashton PD, et al. The genome of the blood fluke Schistosoma mansoni. Nature 2009;460:352-358; PMID:19606141; http://dx.doi.org/10.1038/nature08160
   PubMed Web of Science ®Google Scholar
• Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 2009;460:345-351; PMID:19606140; http://dx.doi.org/10.1038/nature08140
   PubMed Web of Science ®Google Scholar
• Young ND, Jex AR, Li B, Liu S, Yang L, Xiong Z, Li Y, Cantacessi C, Hall RS, Xu X, et al. Whole-genome sequence of Schistosoma haematobium. Nat Genet 2012 44:221-225; PMID:22246508; http://dx.doi.org/10.1038/ng.1065
   PubMed Web of Science ®Google Scholar
• Ganley-Leal LM, Guarner J, Todd CW, Da'Dara AA, Freeman GL Jr, Boyer AE, Harn DA, Secor WE. Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines. Parasite Immunol 2005;27:341-349; PMID:16149992; http://dx.doi.org/10.1111/j.1365-3024.2005.00785.x
   PubMed Web of Science ®Google Scholar
• Minard P, Dean DA, Jacobson RH, Vannier WE, Murrell KD. Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am J Trop Med Hyg 1978;27:76-86; PMID:626284
   PubMed Web of Science ®Google Scholar
• Sher A, Hieny S, James SL, Asofsky R. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes, or complement. J Immunol 1982;128:1880-1884; PMID:6801124
   PubMed Web of Science ®Google Scholar
• Kariuki TM, Farah IO, Yole DS, Mwenda JM, Van Dam GJ, Deelder AM, Wilson RA, Coulson PS. Parameters of the attenuated schistosome vaccine evaluated in the olive baboon. Infect Immun 2004 72:5526-5529; PMID:15322059; http://dx.doi.org/10.1128/IAI.72.9.5526-5529.2004
   PubMed Web of Science ®Google Scholar
• Bethony JM, Cole RN, Guo X, Kamhawi S, Lightowlers MW, Loukas A, Petri w, Reed S, Valenzuela JG, Hotez PJ. Vaccines to combat the neglected tropical diseases. Immunol Rev 2011 239:237-270; PMID:21198676; http://dx.doi.org/10.1111/j.1600-065X.2010.00976.x
   PubMed Web of Science ®Google Scholar
• Capron A, Capron M, Dombrowicz D, Riveau G. Vaccine strategies against schistosomiasis:from concepts to clinical trials. Int Arch Allergy Immunol 2001 124:9-15; PMID:11306914; http://dx.doi.org/10.1159/000053656
   PubMed Web of Science ®Google Scholar
• Tendler M, Brito CA, Vilar MM, Serra-Freire N, Diogo CM, Almeida MS, Delbem AC, Da Silva JF, Savino W, Garratt RC, et al. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc Natl Acad Sci USA 1996 93:269-273
   PubMed Web of Science ®Google Scholar
• https://clinicaltrials.gov/ct2/show/NCT01154049. Accessed on May 2015
   Google Scholar
• Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, Duke M, Don TA, McManus DP, Correa-Oliveira R, Loukas A. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 2006 12:835-840; PMID:16783371; http://dx.doi.org/10.1038/nm1430
   PubMed Web of Science ®Google Scholar
• Da'dara AA, Li YS, Xiong T, Zhou J, Williams GM, McManus DP, Feng Z, Yu XL, Gray DJ, Harn DA. DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 2008 26:3617-3625; PMID:18524429; http://dx.doi.org/10.1016/j.vaccine.2008.04.080
   PubMed Web of Science ®Google Scholar
• Curti E, Kwityn C, Zhan B, Gillespie P, Brelsford J, Deumic V, Pileskatt J, Rezende WC, Tsao E, Kalampanayil B, et al. Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein:a vaccine candidate for human intestinal schistosomiasis. Hum Vaccin Immunother 2013 9:2342-2350; PMID:23899507; http://dx.doi.org/10.4161/hv.25787
   PubMed Web of Science ®Google Scholar
• Ahmad G, Zhang W, Torben W, Haskins C, Diggs S, Noor Z, Le L, Siddiqui AA. Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine. Parasitol Res 2009 105:1767-1777; PMID:19809833; http://dx.doi.org/10.1007/s00436-009-1646-z
   PubMed Web of Science ®Google Scholar
• Ahmad G, Zhang W, Torben W, Ahrorov A, Damian RT, Wolf RF, White GL, Carey DW, Mwinzi PN, Ganley-Leal L, et al. Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic. J Infect Dis 2011 204:1437-1449; PMID:21921206; http://dx.doi.org/10.1093/infdis/jir545
   PubMed Web of Science ®Google Scholar
• Karmakar S, Zhang W, Ahmad G, Torben W, Alam MU, Le L, Damian RT, Wolf RF, White GL, Carey DW, et al. Cross-species protection:Schistosoma mansoni sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons. Vaccine 2014 32:1296-1303; PMID:24397898; http://dx.doi.org/10.1016/j.vaccine.2013.12.057
   PubMed Web of Science ®Google Scholar
• Ricciardi A, Dalton JP, Ndao M. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant. Vaccine 2015 33:346-353; PMID:25448114; http://dx.doi.org/10.1016/j.vaccine.2014.11.016
   PubMed Web of Science ®Google Scholar
• McManus DP, Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev 2008 21:225-242; PMID:18202444; http://dx.doi.org/10.1128/CMR.00046-07
   PubMed Web of Science ®Google Scholar
• http://dailydose.ttuhsc.edu/news/school-of-medicine/ttuhsc-receives-national-grant-2/. Accessed on May 2015
   Google Scholar
• King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helminth infection:a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005 365:1561-1569; PMID:15866310; http://dx.doi.org/10.1016/S0140-6736(05)66457-4
   PubMed Web of Science ®Google Scholar
• Ribeiro de Jesus A, Araújo I, Bacellar O, Magalhães A, Pearce E, Harn D, Strand M, Carvalho EM. Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infect Immun 2000 68:2797-2803; PMID:10768975; http://dx.doi.org/10.1128/IAI.68.5.2797-2803.2000
   PubMed Web of Science ®Google Scholar
• Acosta LP, Aligui GD, Tiu WU, McManus DP, Olveda RM. Immune correlate study on human Schistosoma japonicum in a well-defined population in Leyte, Philippines:I. Assessment of “resistance” versus “susceptibility to S. japonicum infection. Acta Trop 2002 84:127-136; PMID:12429429; http://dx.doi.org/10.1016/S0001-706X(02)00176-6
   PubMed Web of Science ®Google Scholar
• Acosta LP, Waine G, Aligui GD, Tiu WU, Olveda RM, McManus DP. Immune correlate study on human Schistosoma japonicum in a well-defined population in Leyte, Philippines:II. Cellular immune responses to S. japonicum recombinant and native antigens. Acta Trop 2002 84:137-149; PMID:12429430; http://dx.doi.org/10.1016/S0001-706X(02)00177-8
   PubMed Web of Science ®Google Scholar
• Al-Sherbiny M, Osman A, Barakat R, El Morshedy H, Bergquist R, Olds R. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop 2003 88:117-130; PMID:14516923; http://dx.doi.org/10.1016/S0001-706X(03)00195-5
   PubMed Web of Science ®Google Scholar
• Spiegel H, Boes A, Kastilan R, Kapelski S, Edgue G, Beiss V, Chubodova I, Scheuermayer M, Pradel G, Schillberg S, et al. The stage-specific in vitro efficacy of a malaria cocktail provides valuable insights into the development of effective multi-stage vaccines. Biotechnol J 2015.PMID:25913888; http://dx.doi.org/10.1002/biot.201500055
   PubMed Web of Science ®Google Scholar
• Jain K, Jain NK. Vaccines for visceral leishmaniasis:A review. J Immunol Methods 2015; 422:1-12; PMID: 25858230; http://dx.doi.org/10.1016/j.jim.2015.03.017
   PubMed Web of Science ®Google Scholar
• Geiger SM. Immuno-epidemiology of Schistosoma mansoni infections in endemic populations co-infected with soil-transmitted helminths:present knowledge, challenges, and the need for further studies. Acta Trop 2008 108:118-123; PMID:18582842; http://dx.doi.org/10.1016/j.actatropica.2008.05.012
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010:a systematic analysis for the Global Brden of Disease Study 2010. Lancet 2012 380:2163-2196; PMID:23245607; http://dx.doi.org/10.1016/S0140-6736(12)61729-2
   PubMed Web of Science ®Google Scholar
• Hotez PJ, Kamath A. Neglected tropical diseases in sub-saharan Africa:review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009 3:e412; PMID:19707588; http://dx.doi.org/10.1371/journal.pntd.0000412
   PubMed Web of Science ®Google Scholar
• Hotez PJ, Bethony JM, Diemert DJ, Pearson M, Loukas A. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol 2010 8:814-826; PMID:20948553; http://dx.doi.org/10.1038/nrmicro2438
   PubMed Web of Science ®Google Scholar
• Goud GN, Bottazzi ME, Zhan B, Mendez S, Deumic V, Pileskatt J, Liu S, Wang Y, Bueno L, Fujiwara R, et al. Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant proein for use in human clinical trials. Vaccine 2005 23:4754-4764; PMID:16054275; http://dx.doi.org/10.1016/j.vaccine.2005.04.040
   PubMed Web of Science ®Google Scholar
• Damian RT, de la Rosa MA, Murfin DJ, Rawlings CA, Weina PJ, Xue YP. Further development of the baboon as a model for acute schistosomiasis. Mem Inst Oswaldo Cruz 1992 87:261-269; PMID:1343906; http://dx.doi.org/10.1590/S0074-02761992000800041
   PubMed Web of Science ®Google Scholar
• Kennedy RC, Shearer MH, Hildebrand W. Nonhuman primate model to evaluate vaccine safety and immunogenicity. Vaccine 1997 15:903-908; PMID:9234544; http://dx.doi.org/10.1016/S0264-410X(96)00277-0
   PubMed Web of Science ®Google Scholar